Latest Novo Nordisk Stories
PLAINSBORO, N.J., March 26, 2015 /PRNewswire/ -- Novo Nordisk today announced the company will launch Novoeight(®) (Antihemophilic Factor [Recombinant]) in the United States for people living
PLAINSBORO, N.J., March 5, 2015 /PRNewswire/ -- Novo Nordisk has ranked 66 on the FORTUNE "100 Best Companies to Work For(®)" list, marking the seventh consecutive year Novo Nordisk has been
DALLAS, February 20, 2015 /PRNewswire/ -- Global and Chinese Human Insulin Industry, 2009-2019 Market Research Report and Human Insulin Market by Product Type (Human Insulin
LONDON, Feb. 19, 2015 /PRNewswire/ -- In 2013, a total of 382 Million People had diabetes and by 2030 this number is expected to rise to 552 Million.
International Collaboration's initial focus is to solve 3D structures of significant drug targets for diabetes, cancer and mental disorders LOS ANGELES and SHANGHAI, Feb.
The increased adoption of insulin pens and growing number of diagnosed diabetics will drive the US market for modern insulin to over $17 billion by 2020, reports iData Research. Vancouver,